𝔖 Bobbio Scriptorium
✦   LIBER   ✦

178 oral Ototoxicity in targeted supradose cisplatin chemoradiation in irresectable squamous cell carcinoma of the head and neck


Book ID
119515657
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
130 KB
Volume
73
Category
Article
ISSN
0167-8140

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Targeted therapies in squamous cell carc
✍ Kathryn A. Gold; Ho-Young Lee; Edward S. Kim πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 170 KB πŸ‘ 3 views

## Abstract Head and neck cancer is a challenging disease that is expected to account for greater than 500,000 new cases worldwide in 2008. Toxicity has impeded advances in chemotherapy and radiation for head and neck cancer, and the prognosis for patients with recurrent and/or metastatic disease r

Molecular markers predict outcome in squ
✍ Guido B. van den Broek; Maarten Wildeman; Coen R.N. Rasch; Nicola Armstrong; Ed πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 141 KB πŸ‘ 1 views

## Abstract Not all patients with squamous cell carcinomas of the head and neck (HNSCC) benefit from concurrent cisplatin‐based chemoradiation, but reliable predictive markers for outcome after chemoradiation are scarce. We have investigated potential prognostic biomarkers for outcome in a large gr

Identification of cisplatin-resistance r
✍ Yukio Yamano; Katsuhiro Uzawa; Kengo Saito; Dai Nakashima; Atsushi Kasamatsu; Hi πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 355 KB πŸ‘ 2 views

## Abstract Resistance to cisplatin is a major obstacle to successful treatment of head and neck squamous cell carcinoma (HNSCC). To investigate the molecular mechanism of this resistance, we compared the gene expression profiles between the cisplatin‐sensitive SCC cell lines (Sa‐3, H‐1 and KB) and